Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Giorgetti

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 24, 2023
Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in ItalySimone Saibeni, Michela Zanetti, Cristina Bezzio, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2010
Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonismMarco Giorgetti, Jacqueline A Gibbons, Sebastián Bernales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 26, 2009
Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway functionLuna Abdallah, Stephen J Bonasera, F Woodward Hopf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 13, 2004
Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockadeThomas I F H Cremers, Marco Giorgetti, Fokko J Bosker, et al.
Neurobiology of Disease|November 5, 2021
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's diseaseEva Nordström, Fredrik Eriksson, Jessica Sigvardson, et al.
The American Journal of Gastroenterology|June 3, 2010
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled studyAntonio Tursi, Giovanni Brandimarte, Alfredo Papa, et al.
Digestive Diseases (Basel, Switzerland)|December 23, 2014
Development and validation of an endoscopic classification of diverticular disease of the colon: the DICA classificationAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
Advances in Therapy|May 9, 2026
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort StudyAntonio Tursi, Andrea Pasta, Walter Elisei, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 24, 2023
Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in ItalySimone Saibeni, Michela Zanetti, Cristina Bezzio, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2010
Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonismMarco Giorgetti, Jacqueline A Gibbons, Sebastián Bernales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 26, 2009
Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway functionLuna Abdallah, Stephen J Bonasera, F Woodward Hopf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 13, 2004
Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockadeThomas I F H Cremers, Marco Giorgetti, Fokko J Bosker, et al.
Neurobiology of Disease|November 5, 2021
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's diseaseEva Nordström, Fredrik Eriksson, Jessica Sigvardson, et al.
The American Journal of Gastroenterology|June 3, 2010
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled studyAntonio Tursi, Giovanni Brandimarte, Alfredo Papa, et al.
Digestive Diseases (Basel, Switzerland)|December 23, 2014
Development and validation of an endoscopic classification of diverticular disease of the colon: the DICA classificationAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
Advances in Therapy|May 9, 2026
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort StudyAntonio Tursi, Andrea Pasta, Walter Elisei, et al.
Pageof 7